Cryptogenic Stroke: Etiology, Diagnosis & Recurrent Preventive Management
Program Date: Tuesday, Mar. 11, 2014
This activity is jointly sponsored by Medical Education Resources and National Stroke Association
Stroke is the leading cause of long-term severe disability and the fourth cause of death in the U.S. Roughly 30-40% of first time strokes are cryptogenic, or due to unknown cause. It is necessary to establish the cause of stroke to determine functional prognosis, decrease the risk of future strokes, and select appropriate preventative care. Currently, serious gaps exist between in the clinical knowledge of cryptogenic stroke and how to treat, manage, and prevent the occurrence—leaving patients at risk for disabling strokes or even death.
Goals and Learning Objectives
The goal of the Cryptogenic Stroke: Etiology, Diagnostics and Recurrent Preventative Management initiative is to educate healthcare professionals on cryptogenic stroke to ensure accurate diagnostic testing, diagnosis and treatment to prevent recurrent strokes. Through participation in this activity, learners should be able to:
- Review the definition and frequency of cryptogenic stroke
- Discuss management options for recurrent stroke before cause of stroke is determined
- Discuss diagnostic tests to monitor and test for cryptogenic stroke
- Review evidence-based treatment options to repair Patent Foramen Ovale (PFO) and manage cryptogenic stroke to prevent recurrent stroke
The target audience for the Cryptogenic Stroke: Etiology, Diagnostics and Recurrent Preventative Management activity includes stroke nurse coordinators, neuroscience nurses and other nurses who work with stroke patients.
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.
All participants must complete the post-test and evaluation in order to receive proper credit for attending. There are no fees for participating in and receiving credit for this activity.
Content Developed and Presented By
Philip Gorelick, MD, MPH, FACP, FAAN, FAHA, FANA
Professor, Translational Science & Molecular Medicine
Michigan State University College of Human Medicine
Medical Director, Mercy Health Hauenstein Neurosciences
Grand Rapids, Michigan
Jason M. Lazar, MD, MPH, FACC, FACP
Professor of Medicine
Director, Non-Invasive Cardiology
Director, Cardiovascular Medicine Fellowship Training Program
Clinical Assistant Dean, College of Medicine
SUNY Downstate Medical Center
Disclosure of Conflict of Interest
Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all its educational activities. In accordance with this policy, Medical Education Resources identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Medical Education Resources resolves conflicts to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. Medical Education Resources is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
Name of Faculty
Dr. Philip Gorelick
Reported Financial Relationship
Boehringer Ingelheim and
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
Michelle Murdock, Consultant, No financial relationship
Veronda K Smith, FNP-BC, No financial relationships to disclose
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Medtronic, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Medtronic, Inc. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.